Skip to content
Home/Companies/HealthTech/Synapse Medicine

Synapse Medicine

HealthTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Synapse Medicine?

Synapse Medicine is a French HealthTech company, currently owned by Korelya Capital since 2022 and XAnge.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Korelya Capital
Most recent investor
Korelya Capital
K-Fund II · 2021 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthTech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by XAnge and Korelya Capital since 2018.
Co-invest · 2 holders · 2018 · present
XAnge
XAngeActive
2018 · present(8yr) · Digital 3 · 2017 · VC
Korelya Capital
Korelya CapitalActive
2022 · present(4yr) · K-Fund II · 2021 · VC

More from K-Fund II

Other portfolio companies in the same fund.

DeepIP
DeepIP
Active
AI/MLFrance· 2026
Theker Robotics
Active
Deep TechSpain· 2026
Gradium
Active
AI/MLFrance· 2025
Junction
Active
SoftwareSweden· 2025
ifeel
ifeel
Active
HealthTechSpain· 2024
Mistral AI
Active
AI/MLFrance· 2024

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Synapse Medicine?

Synapse Medicine is currently owned by Korelya Capital and XAnge, through K-Fund II, since 2022.

When did Korelya Capital and 1 other acquire Synapse Medicine?

Korelya Capital and 1 other acquired Synapse Medicine in 2022.

Who has owned Synapse Medicine over time?

Synapse Medicine has been through 2 private-equity ownership periods: XAnge · via Digital 3 · since 2018; Korelya Capital · via K-Fund II · since 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue